Why Freshpet (FRPT) Shares Are Down 11% Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- US stock futures gain ahead of July inflation data
- Oil prices rise after ship attacks, US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Freshpet (FRPT) PT Lowered to $125 at Jefferies
December 20, 2021 8:21 AM ESTJefferies analyst Stephanie Wissink lowered the price target on Freshpet (NASDAQ: FRPT) to $125.00 (from $175.00) while maintaining a Buy rating.
... MoreFreshpet (FRPT) PT Lowered to $150 at Baird, Recommends Buying on Weakness
December 20, 2021 6:25 AM ESTBaird analyst Peter Benedict lowered the price target on Freshpet (NASDAQ: FRPT) to $150.00 (from $185.00) while maintaining an Outperform rating after supply chain issues led to a Q4 earning.
The analyst said they would be buyers on weakness.
... MoreFreshpet (FRPT) PT Lowered to $135 at Stifel Following Reduced Outlook
December 17, 2021 10:40 AM ESTStifel analyst Mark Astrachan lowered the price target on Freshpet (NASDAQ: FRPT) to $135.00 (from $165.00) while maintaining a Buy rating after the company reduced 2021 sales and adjusted EBITDA expectations, now anticipating $115mm-$120mm for 4Q21 sales, compared to consensus of $133mm.
The analyst... More
